HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) headquartered in Tucson, will host a conference call for the investment community to discuss the 3Q20 financial results on 10th November 2020 at 4:30 PM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.htgmolecular.com
Earnings Expectation
HTG Molecular Diagnostics, Inc. is set to announce third quarter earning results on Tuesday 10th November 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, HTGM to report 3Q20 loss of $ 0.08 per share. For the full year, analysts anticipate top line of $ 9.92 million, while looking forward to loss of $ 0.32 per share bottom line.
HTG Molecular Diagnostics, Inc. a commercial stage life sciences company, focuses on the precision medicine. The company offers instrumentation (or platforms); consumables comprising assay kits; and software analytics that automate sample processing and profiles various molecular targets.
